Harsha Murthy is a senior financial and pharmaceuticals/biotech executive with extensive experience in operations, finance, strategic planning, business development and licensing in a variety of corporate settings. Mr. Murthy currently is managing partner of Consummate Capital LLC, a New York City-based investment and advisory firm that sources and structures the acquisition of generic and branded pharmaceutical products for its clients. Mr. Murthy most recently served as co-founder and managing partner of Konanda Pharma Partners, a New York City-based private equity fund that invested in branded and marketed specialty pharmaceutical products and built portfolio companies to make and market those drug products. At Konanda, Mr. Murthy led the acquisition of major products from “Big Pharma” companies such as Roche and Shire and formed multiple portfolio companies (including hiring operating management) to market and grow the pharmaceutical assets Konanda acquired. 

Prior to founding Konanda, Mr. Murthy served as Executive Vice President and Corporate Head- Strategic Planning and Business Development for King Pharmaceuticals, Inc., a vertically integrated branded pharmaceuticals company with over $1 billion in annual revenues. Mr. Murthy was responsible for all of King’s mergers, acquisitions, in-licensing, partnership and investment banking relationships. In this capacity at King, Mr. Murthy identified, led and closed a number of significant transactions including King’s strategic partnerships with Palatin Technologies and Pain Therapeutics, divestitures of several of King’s late-stage products, and acquisitions of product rights from “Big Pharma” across a number of therapeutic areas.